Two-stage selection and testing designs for comparative clinical trials
From MaRDI portal
Publication:3780331
DOI10.1093/BIOMET/75.2.303zbMATH Open0639.62096OpenAlexW2064399851MaRDI QIDQ3780331FDOQ3780331
Authors: Peter F. Thall, Susan S. Ellenberg, Richard Simon 
Publication date: 1988
Published in: Biometrika (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1093/biomet/75.2.303
Recommendations
- A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials
- A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard
- A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard: The Case of Common, Known Variance
- scientific article; zbMATH DE number 3856244
- A two-stage design for comparative clinical trials: the heteroscedastic solution
clinical trialsselectionexpected sample sizetwo-stage procedurecomparison with a controlcut-off parameters
Applications of statistics to biology and medical sciences; meta analysis (62P10) Statistical ranking and selection procedures (62F07) Optimal statistical designs (62K05)
Cited In (52)
- Authors' Responses
- On estimating the mean of the selected normal population in two-stage adaptive designs
- Discussion on “A Hybrid Selection and Testing Procedure with Curtailment in Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen
- Discussion on “A Hybrid Selection and Testing Procedure with Curtailment” by Elena M. Buzaianu and Pinyuen Chen
- Normal approximation for two-stage winner design
- A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials
- A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard: The Case of Common, Known Variance
- A selection and testing procedure for comparing several experimental treatments with a control
- One-Stage and Two-Stage Designs for Clinical Trials Using an Indifference-Zone Approach
- Estimation following selection of the largest of two normal means
- Decision-Theoretic Designs for Phase II Clinical Trials Allowing for Competing Studies
- A Two-Stage Selection and Testing Design for Comparing Several Normal Means with a Standard
- Title not available (Why is that?)
- A two-stage design for comparative clinical trials: the heteroscedastic solution
- A curtailed procedure for selecting among treatments with two Bernoulli endpoints
- On design and inference for two-stage adaptive clinical trials with dependent data
- Comparing exponential clinical trials by combining individual sequential experiments available from independent studies
- Two‐Stage Designs for Dose‐Finding Trials with a Biologic Endpoint Using Stepwise Tests
- A Two-Stage Design for Choosing among Several Experimental Treatments and a Control in Clinical Trials
- Design and sample size determination for multiple-dose randomized phase II trials for dose optimization
- A multi-arm multi-stage platform design that allows preplanned addition of arms while still controlling the family-wise error
- Point estimates and confidence regions for sequential trials involving selection
- Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen
- Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen
- Discussion on “A Hybrid Selection and Testing Procedure with Curtailment for Comparative Clinical Trials” by Elena M. Buzaianu and Pinyuen Chen
- Two-Stage Designs with Additional Futility Tests for Phase II Clinical Trials with Heterogeneous Patient Populations
- Adaptive two-stage test procedures to find the best treatment in clinical trials
- Admissible and minimax estimation of the parameters of the selected normal population in two-stage adaptive under reflected normal loss function
- Simple Sequential Boundaries for Treatment Selection in Multi‐Armed Randomized Clinical Trials with a Control
- Statistical tests for two-stage adaptive seamless design using short- and long-term binary outcomes
- Adjusting for treatment selection in phase II/III clinical trials with time to event data
- A randomized two stage adaptively censored design with application to testing
- Curtailment Procedure for Selecting Among Bernoulli Populations
- Benefit–Risk Evaluation of Multi-Stage Adaptive Designs
- Sequential estimation for two-stage and three-stage clinical trials
- Choosing sample size for a clinical trial using decision analysis
- Bayesian approach to two-stage phase trial
- Fixed and sequential treatment allocation in clinical trials
- Seamlessly expanding a randomized phase II trial to phase III
- Title not available (Why is that?)
- A two-stage design for comparing binomial treatments with a standard
- Two-stage winner designs for non-inferiority trials with pre-specified non-inferiority margin
- On Selecting Among Treatments with Binomial Outcomes
- Product-Type Probability Bounds of Higher Order
- SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION
- Sample size re-estimation for confirmatory two-stage flexible multi-arm trial with normal outcomes
- Title not available (Why is that?)
- Two Stage Sampling for Simultaneously Testing Main and Side Effects in Clinical Trials
- A hybrid geometric phase II/III clinical trial design based on treatment failure time and toxicity
- A comparison of methods for constructing confidence intervals after phase II/III clinical trials
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
- A review of phase 2-3 clinical trial designs
This page was built for publication: Two-stage selection and testing designs for comparative clinical trials
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3780331)
